4//SEC Filing
REESE DAVID M 4
Accession 0001127602-24-009247
CIK 0000318154other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:32 PM ET
Size
5.5 KB
Accession
0001127602-24-009247
Insider Transaction Report
Form 4
AMGEN INCAMGN
REESE DAVID M
EVP & Chief Technology Officer
Transactions
- Award
Common Stock
2024-03-06+12,407→ 66,653 total
Footnotes (2)
- [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 2,685 RSUs which will vest in installments of 1,322 on 4/30/2024 and 1,363 on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 each on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 715 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001748434
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:32 PM ET
- Size
- 5.5 KB